The COVID-19 vaccine to be administered to the 12-14 years age group would be Corbevax manufactured by Biological Evans, Hyderabad.
'Society deals with you the way they do, or forms an opinion, depending on if your family is with you every step of the way.'
Navratri are the days to show off lehenga-cholis with the most striking prints and the finest embroidery that exists on this planet
Days after clusters of recombinant Delta and Omicron variants of coronavirus were reported from across the world, a leading virologist said there was no need to panic at the moment.
Invest in quality companies that make profits, advises stock market expert and rediffGURU Samraat Jadhav.
The foreign envoys were taken to Hyderabad over a month after the ministry of external affairs briefed over 190 heads of diplomatic missions and representatives of leading international organisations on COVID-19 related issues.
'If it weren't for Om Puri, a whole range of our big city experiences wouldn't have found their honest representations on the screen.'
A senior Delhi Jal Board (DJB) official on Sunday bathed in water taken from a stretch of the Yamuna where the utility sprayed a chemical to dissipate foam in the river.
India is not keen to 'bow down' to demands related to indemnity against legal liabilities in case any vaccine recipient develops severe adverse reactions post inoculation.
Noel Rodriguez-Alvarez, who has special needs, was last seen in November shortly after his twin sisters were born in October last year.
This is for the first time that a booster dose that is different from the one used for primary vaccination against COVID has been allowed in the country.
A bench comprising Chief Justice DY Chandrachud and Justice PS Narasimha took note of the plea of social activist Jaya Thakur, a Madhya Pradesh-based doctor, and issued notices to the central government and all the states and UTs.
The research would lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics, an institute spokesperson said on Wednesday.
Anurag Agrawal, the Director of the Institute of Genomics and Integrative Biology, said the study on effectiveness of the available vaccines on the B.1.617 variant of SARS-CoV2 suggests that post vaccination, the infections are milder.
The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Outlining the wish list for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said the domestic pharma industry is currently around $50 billion in size and aspires to grow to around $130 billion by 2030 and $450 billion by 2047. "To achieve this vision, the Union Budget 2023-2024 should help fuel innovation and R&D, which will set the pace for propelling the pharmaceutical industry forward," he told PTI.
On the whole, the case for Period Leave is compelling. It may well bring more women into the workforce. But the concept will likely be hostage to the whims of enlightened companies, notes Kanika Datta.
'These number surges will be the outcome of emerging virus variants, loss of vaccine- or infection-acquired protective immunity in people, and environmental factors'
Deepa Gahlot lists 10 popular Mani Ratnam films that you can watch on streaming platforms.
'And Joshimath has already shown the dangers ahead.' 'We have to acknowledge that our mountains are still young babies.' 'You don't put an extra load on the back of a growing child!'
'At any point did you find out why Sheena had not disclosed her true relationship with Indrani?' Rahul: 'Sheena had told me as her grandparents were dependent on Indrani financially (and if she told the truth) her grandparents would suffer.' 'She had slapped Sheena the night before which she was very not happy about.'
The B.1.617 variant of SARS-CoV2, also being called a 'double mutant' or the 'Indian strain', has been found prevalent largely in Maharashtra and Delhi that have been severely hit by a devastating second wave of the pandemic.
I suggest we build a Vigyan Mandir (Temple of Science) with the ambience of a place of worship, so that it becomes a destination for pilgrims. We should embed on its walls bronze plaques describing each scientist mentioned here along with about a dozen of our ancient mathematicians, recommends Professor Kalyan Singhal, historian of science and technology.
John and Tamilarasi had their newborn stolen eight years ago, and lost all hope of ever finding him. Now they have got him back, though not fully. Not yet.
Russian President Vladimir Putin on Wednesday monitored drills of the country's strategic nuclear forces involving multiple practice launches of ballistic and cruise missiles, the Kremlin said.
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
The paper also includes musing that SARS -- which hit China in 2003 -- could have been a man-made bioweapon deliberately unleashed by "terrorists".
Whenever there is an evaluation scheme, it is human tendency to score as high as possible. None would like to highlight their shortcomings, and everyone likes to highlight their positives. This is what is happening in this context of rankings as well, points out Profesor N Ravichandran.
Rahul Mukerjea's two-day cross examination in early November left many questions unanswered even as new ones came to the fore in the Sheena Bora Murder Trial, reports Prasanna D Zore.
Ahead of his crucial talks with Russian President Vladimir Putin in Moscow, Chinese President Xi Jinping said on Monday that his peace plan to end the raging Ukraine war takes into account the 'legitimate' concerns of all parties and reflects the broadest common understanding of the international community.
The Standing Technical Sub-Committee (STSC) of the National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended reducing the gap between the second and precaution doses of COVID-19 vaccines from the current nine to six months, official sources said.
The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.
Announcements will be made on airplanes, ships, metros and at railway stations when India achieves its target of 100 crore COVID-19 vaccine doses while private carrier Spicejet will wrap its planes with posters of this milestone carrying images of Prime Minister Narendra Modi and health workers, health minister Mansukh Mandaviya said on Thursday.
Subhash K Jha remembers Dilip Kumar on the screen legend's first death anniversary, July 7.
Amid mounting concerns over the new 'XE' variant of Covid and a day after the Brihanmumbai Municipal Corporation reported its first case in Mumbai, Maharashtra Health Minister Rajesh Tope on Thursday said the state health department has not received any confirmation about the variant and thus cannot confirm it.
Charities and organisations are boycotting the event following a dispute over conversion therapy for transgender people
The child was apparently carrying a packet containing some food item when the dogs pounced on him, a Greater Hyderabad Municipal Corporation (GHMC) official said.
For the first time in Maharashtra, four patients of B.A.4 sub-lineage and three cases of B.A.5 sub-lineage of the Omicron variant of coronavirus have been found, the state health department said on Saturday.
'Whether the substantial hybrid immunity present in India can protect against severe consequences of the disease remains to be seen.'
Over 3 lakh children between 12 and 14 years have received their first shot of Covid vaccine taking the total doses administered in the country to over 180.80 crore, according to Union health ministry data.
Addressing a press briefing, Union Health Secretary Rajesh Bhushan said Zydus Cadila, Sputnik V, Biological E and Gennova are other vaccines also in the pipeline which are in advanced clinical trials in India.
